vs
AMERICAN STATES WATER CO（AWR）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是AMERICAN STATES WATER CO的1.3倍（$219.9M vs $164.3M），AMERICAN STATES WATER CO净利率更高（17.5% vs -1.0%，领先18.5%），AMERICAN STATES WATER CO同比增速更快（14.8% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-36.0M），过去两年AMERICAN STATES WATER CO的营收复合增速更高（10.2% vs 8.0%）
美国州水公司是美国的上市公用事业企业，通过旗下子公司在全美范围内提供自来水供应及污水处理相关服务，服务覆盖居民、商业及公共机构等多元客户群体，是当地水务服务领域的重要参与企业。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
AWR vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.3倍
$164.3M
营收增速更快
AWR
高出12.8%
2.0%
净利率更高
AWR
高出18.5%
-1.0%
自由现金流更多
OFIX
多$52.8M
$-36.0M
两年增速更快
AWR
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $164.3M | $219.9M |
| 净利润 | $28.7M | $-2.2M |
| 毛利率 | 88.9% | 71.1% |
| 营业利润率 | 27.4% | 0.2% |
| 净利率 | 17.5% | -1.0% |
| 营收同比 | 14.8% | 2.0% |
| 净利润同比 | 1.1% | 92.4% |
| 每股收益（稀释后） | $0.74 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AWROFIX
| Q4 25 | $164.3M | $219.9M | ||
| Q3 25 | $182.7M | $205.6M | ||
| Q2 25 | $163.1M | $203.1M | ||
| Q1 25 | $148.0M | $193.6M | ||
| Q4 24 | $143.1M | $215.7M | ||
| Q3 24 | $161.8M | $196.6M | ||
| Q2 24 | $155.3M | $198.6M | ||
| Q1 24 | $135.3M | $188.6M |
净利润AWROFIX
| Q4 25 | $28.7M | $-2.2M | ||
| Q3 25 | $41.2M | $-22.8M | ||
| Q2 25 | $33.7M | $-14.1M | ||
| Q1 25 | $26.8M | $-53.1M | ||
| Q4 24 | $28.4M | $-29.1M | ||
| Q3 24 | $35.8M | $-27.4M | ||
| Q2 24 | $31.9M | $-33.4M | ||
| Q1 24 | $23.1M | $-36.0M |
毛利率AWROFIX
| Q4 25 | 88.9% | 71.1% | ||
| Q3 25 | 91.0% | 72.2% | ||
| Q2 25 | 92.1% | 68.7% | ||
| Q1 25 | 91.3% | 62.8% | ||
| Q4 24 | 92.4% | 69.0% | ||
| Q3 24 | 92.7% | 68.7% | ||
| Q2 24 | 89.6% | 67.8% | ||
| Q1 24 | 88.4% | 67.5% |
营业利润率AWROFIX
| Q4 25 | 27.4% | 0.2% | ||
| Q3 25 | 33.8% | -8.3% | ||
| Q2 25 | 31.3% | -7.9% | ||
| Q1 25 | 30.8% | -25.2% | ||
| Q4 24 | 27.0% | -5.3% | ||
| Q3 24 | 34.0% | -9.6% | ||
| Q2 24 | 33.3% | -12.5% | ||
| Q1 24 | 28.8% | -15.6% |
净利率AWROFIX
| Q4 25 | 17.5% | -1.0% | ||
| Q3 25 | 22.5% | -11.1% | ||
| Q2 25 | 20.7% | -6.9% | ||
| Q1 25 | 18.1% | -27.4% | ||
| Q4 24 | 19.9% | -13.5% | ||
| Q3 24 | 22.1% | -13.9% | ||
| Q2 24 | 20.5% | -16.8% | ||
| Q1 24 | 17.1% | -19.1% |
每股收益（稀释后）AWROFIX
| Q4 25 | $0.74 | $-0.05 | ||
| Q3 25 | $1.06 | $-0.57 | ||
| Q2 25 | $0.87 | $-0.36 | ||
| Q1 25 | $0.70 | $-1.35 | ||
| Q4 24 | $0.75 | $-0.76 | ||
| Q3 24 | $0.95 | $-0.71 | ||
| Q2 24 | $0.85 | $-0.88 | ||
| Q1 24 | $0.62 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.8M | $82.0M |
| 总债务越低越好 | $782.7M | — |
| 股东权益账面价值 | $1.0B | $450.0M |
| 总资产 | $2.7B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.75× | — |
8季度趋势，按日历期对齐
现金及短期投资AWROFIX
| Q4 25 | $18.8M | $82.0M | ||
| Q3 25 | $26.1M | $62.9M | ||
| Q2 25 | $20.2M | $65.6M | ||
| Q1 25 | $21.2M | $58.0M | ||
| Q4 24 | $26.7M | $83.2M | ||
| Q3 24 | $16.5M | $30.1M | ||
| Q2 24 | $3.6M | $26.4M | ||
| Q1 24 | $17.0M | $27.0M |
总债务AWROFIX
| Q4 25 | $782.7M | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $640.4M | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益AWROFIX
| Q4 25 | $1.0B | $450.0M | ||
| Q3 25 | $1.0B | $442.5M | ||
| Q2 25 | $972.5M | $458.3M | ||
| Q1 25 | $956.4M | $458.3M | ||
| Q4 24 | $920.1M | $503.1M | ||
| Q3 24 | $879.5M | $525.9M | ||
| Q2 24 | $833.5M | $546.0M | ||
| Q1 24 | $800.5M | $570.3M |
总资产AWROFIX
| Q4 25 | $2.7B | $850.6M | ||
| Q3 25 | $2.7B | $832.6M | ||
| Q2 25 | $2.6B | $837.2M | ||
| Q1 25 | $2.5B | $823.1M | ||
| Q4 24 | $2.5B | $893.3M | ||
| Q3 24 | $2.4B | $867.9M | ||
| Q2 24 | $2.3B | $882.0M | ||
| Q1 24 | $2.3B | $906.0M |
负债/权益比AWROFIX
| Q4 25 | 0.75× | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | 0.70× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-36.0M | $16.8M |
| 自由现金流率自由现金流/营收 | -21.9% | 7.6% |
| 资本支出强度资本支出/营收 | 38.8% | 4.9% |
| 现金转化率经营现金流/净利润 | 0.96× | — |
| 过去12个月自由现金流最近4个季度 | $-7.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流AWROFIX
| Q4 25 | $27.7M | $27.7M | ||
| Q3 25 | $92.4M | $12.4M | ||
| Q2 25 | $64.6M | $11.6M | ||
| Q1 25 | $45.1M | $-18.4M | ||
| Q4 24 | $64.5M | $23.7M | ||
| Q3 24 | $63.7M | $11.7M | ||
| Q2 24 | $24.7M | $9.0M | ||
| Q1 24 | $45.8M | $-18.6M |
自由现金流AWROFIX
| Q4 25 | $-36.0M | $16.8M | ||
| Q3 25 | $37.7M | $2.5M | ||
| Q2 25 | $13.7M | $4.5M | ||
| Q1 25 | $-22.5M | $-25.1M | ||
| Q4 24 | $6.0M | $15.2M | ||
| Q3 24 | $-478.0K | $6.3M | ||
| Q2 24 | $-37.0M | $-360.0K | ||
| Q1 24 | $-1.7M | $-29.1M |
自由现金流率AWROFIX
| Q4 25 | -21.9% | 7.6% | ||
| Q3 25 | 20.7% | 1.2% | ||
| Q2 25 | 8.4% | 2.2% | ||
| Q1 25 | -15.2% | -13.0% | ||
| Q4 24 | 4.2% | 7.0% | ||
| Q3 24 | -0.3% | 3.2% | ||
| Q2 24 | -23.8% | -0.2% | ||
| Q1 24 | -1.3% | -15.4% |
资本支出强度AWROFIX
| Q4 25 | 38.8% | 4.9% | ||
| Q3 25 | 29.9% | 4.8% | ||
| Q2 25 | 31.2% | 3.5% | ||
| Q1 25 | 45.6% | 3.5% | ||
| Q4 24 | 40.9% | 4.0% | ||
| Q3 24 | 39.7% | 2.7% | ||
| Q2 24 | 39.8% | 4.7% | ||
| Q1 24 | 35.2% | 5.6% |
现金转化率AWROFIX
| Q4 25 | 0.96× | — | ||
| Q3 25 | 2.24× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 1.68× | — | ||
| Q4 24 | 2.27× | — | ||
| Q3 24 | 1.78× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 1.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AWR
| Water Service Utility Operations | $110.0M | 67% |
| Public Utilities Inventory Water | $22.3M | 14% |
| Wastewater | $15.9M | 10% |
| Electric Service Utility Operations | $15.2M | 9% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
